Chadwick Jeremy G bought KYMR
April 14, 2026 · Form 4 insider transaction
Chadwick Jeremy G bought 4,466 shares of Kymera Therapeutics, Inc. at $30.17 per share, a transaction worth $134.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,466
Price
$30.17
Total value
$134.7K
InsiderChadwick Jeremy G
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 14, 2026
Filing dateApril 16, 2026
Shares owned after65,668
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.